Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Donald W. Northfelt, MD, FACP
Mayo Clinic
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
92 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic Scottsdale
Scottsdale, Arizona, United States
- Saint Francis/mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
Hartford, Connecticut, United States
- Mayo Clinic - Jacksonville
Jacksonville, Florida, United States
- St. Francis Hospital and Health Centers - Beech Grove Campus
Beech Grove, Indiana, United States
- Reid Hospital & Health Care Services
Richmond, Indiana, United States
- Cedar Rapids Oncology Associates
Cedar Rapids, Iowa, United States
- Mercy Regional Cancer Center at Mercy Medical Center
Cedar Rapids, Iowa, United States
- Medical Oncology and Hematology Associates - West Des Moines
Clive, Iowa, United States
- Ccop - Iowa Oncology Research Association
Des Moines, Iowa, United States
- John Stoddard Cancer Center at Iowa Lutheran Hospital
Des Moines, Iowa, United States
- John Stoddard Cancer Center at Iowa Methodist Medical Center
Des Moines, Iowa, United States
- Medical Oncology and Hematology Associates at John Stoddard Cancer Center
Des Moines, Iowa, United States
- Medical Oncology and Hematology Associates at Mercy Cancer Center
Des Moines, Iowa, United States
- Mercy Cancer Center at Mercy Medical Center - Des Moines
Des Moines, Iowa, United States
- Mercy Cancer Center at Mercy Medical Center - North Iowa
Mason City, Iowa, United States
- Mccreery Cancer Center at Ottumwa Regional
Ottumwa, Iowa, United States
- Mercy Medical Center - Sioux City
Sioux City, Iowa, United States
- Siouxland Hematology-Oncology Associates, Llp
Sioux City, Iowa, United States
- St. Luke'S Regional Medical Center
Sioux City, Iowa, United States
- Ccop - Michigan Cancer Research Consortium
Ann Arbor, Michigan, United States
- Saint Joseph Mercy Cancer Center
Ann Arbor, Michigan, United States
- Battle Creek Health System Cancer Care Center
Battle Creek, Michigan, United States
- Mecosta County Medical Center
Big Rapids, Michigan, United States
- Oakwood Cancer Center at Oakwood Hospital and Medical Center
Dearborn, Michigan, United States
- Genesys Hurley Cancer Institute
Flint, Michigan, United States
- Hurley Medical Center
Flint, Michigan, United States
- Butterworth Hospital at Spectrum Health
Grand Rapids, Michigan, United States
- Ccop - Grand Rapids
Grand Rapids, Michigan, United States
- Lacks Cancer Center at Saint Mary'S Health Care
Grand Rapids, Michigan, United States
- Van Elslander Cancer Center at St. John Hospital and Medical Center
Grosse Pointe Woods, Michigan, United States
- Foote Memorial Hospital
Jackson, Michigan, United States
- Sparrow Regional Cancer Center
Lansing, Michigan, United States
- St. Mary Mercy Hospital
Livonia, Michigan, United States
- Mercy General Health Partners
Muskegon, Michigan, United States
- St. Joseph Mercy Oakland
Pontiac, Michigan, United States
- Mercy Regional Cancer Center at Mercy Hospital
Port Huron, Michigan, United States
- Seton Cancer Institute at Saint Mary'S - Saginaw
Saginaw, Michigan, United States
- Munson Medical Center
Traverse City, Michigan, United States
- St. John Macomb Hospital
Warren, Michigan, United States
- Metro Health Hospital
Wyoming, Michigan, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2008
- Primary completion
- 31 Aug 2010
- Completion
- 31 Aug 2013
- Last update posted
- 17 Apr 2017
- Registered enrollment
- 50
- Registry id
- NCT00662129
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.